化学疗法引起的恶心和呕吐的启示：一项随机临床试验。
摘要来源：
oncol Nurs Nurs Forum。 2007年7月; 34（4）：813-20。 PMID： 17723973“ Misha Cohen，Brenda Nussey，Hope Rugo
文章隶属关系：加利福尼亚大学旧金山大学护理学院卫生与老化研究所。 class =“ sub_abstract_label”>目的/目标： 比较三组女性（穴位化，安慰剂启动和通常的护理）接受化学疗法引起的恶心和呕吐（CINV）的差异，接受乳腺癌的化学疗法。">DESIGN: A multicenter, longitudinal, randomized clinical trial throughout one cycle of chemotherapy.
SETTING: Ten community clinical oncology programs associated with the M.D. Anderson Cancer Center and nine independent sites located throughout the United States.
SAMPLE: 160 women who were beginning their second or third cycle of chemotherapy for breast cancer treatment and had moderate nausea intensity scores with their previous cycles.
METHODS: Subjects were randomized to one of three groups: acupressure to P6 point （活跃），仅在穴位上进行SI3点（安慰剂）或通常的护理。ures of nausea and vomiting and recording methods (including antiemetics and acupressure) used to control these symptoms.
MAIN RESEARCH VARIABLES: Acute and delayed nausea and vomiting.
RESULTS: 在治疗组中人口，疾病或治疗变量中没有显着差异。通过治疗组，急性恶心或呕吐没有发现显着差异。随着恶心和呕吐的延迟，与安慰剂和通常的护理组相比，呕吐量和恶心的呕吐量和恶心的强度在统计学上显着降低。在延迟的恶心或呕吐中，安慰剂和通常的护理组之间没有发现显着差异。
结论： p6 point是一种增值技术。接受治疗乳腺癌治疗的妇女的饮食，以减少延迟CINV的数量和强度。
对护理的影响： cacupressure是一种安全有效的工具，可以为延迟延迟cinv提供乳腺癌的妇女，以供乳腺癌进行化学疗法。